IPCA Labs stock up 40% in 2019: Here is why the scrip has outperformed benchmarks Updated : November 19, 2019 02:44 PM IST IPCA is a rare case of outperformance; the stock has given returns despite facing USFDA compliance issues. The company also seems to be rediscovering its mojo in the institutional malaria business.